Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Octreotide acetate (0.1mg) Injection
Therapeutic Category
Endocrinology, ENDOCRINOLOGY and Hormonal range, Gastroenterology
Dosage Form
Injection
Packaging Type
Ampule
Packaging
1x5ml
Price
₹1/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Octrate 0.1 Injection containing Octreotide Acetate is used for the management of hormonal and gastrointestinal disorders. It helps in controlling excessive hormone secretion and related complications.
Octreotide works as a somatostatin analogue that inhibits the release of various hormones and gastrointestinal secretions, helping manage associated medical conditions effectively.
The injection is widely used in gastroenterology, endocrinology, and critical care settings, leading to consistent demand in hospital and specialty care segments.
With increasing demand for advanced critical care and hormonal management therapies, this product offers strong business potential for distributors and institutional suppliers. Its specialized therapeutic application, hospital-based usage, and steady clinical demand make it a reliable product for consistent sales and growth in the specialty care segment.
Some patients may experience abdominal pain, nausea, diarrhea, injection site discomfort, or headache. Rarely, gallstones, blood sugar fluctuations, or thyroid function changes may occur and require medical attention.
Octrate 0.1 Injection is indicated for the treatment of acromegaly, carcinoid tumors, vasoactive intestinal peptide-secreting tumors (VIPomas), and management of bleeding esophageal varices. It helps control hormone overproduction, reduce gastrointestinal symptoms, and manage severe secretory conditions.
This injection should be administered under medical supervision. Regular monitoring of blood glucose, gallbladder function, and hormone levels may be required during therapy. Use cautiously in patients with diabetes or liver disorders.
Store in a refrigerator between 2°C to 8°C. Do not freeze. Protect from light and keep out of reach of children.
Composition : Omeprazole (20mg) Capsule
Composition : Domperidone (10mg) + Omeprazole (20mg) in Strip Packing of 15 Tablets
Composition : Pantoprazole (E.C.) I.P. 40mg (E.C.) + Domperidone (I.R.) I.P. 10mg + Domperidone (S.R.) I.P. 20mg Capsules
Composition : Pantoprazole (40mg) + Itopride (150mg)
Composition : Rabeprazole Sodium (E.C.) I.P. 20mg + Domperidone (S.R.) I.P. 20mg + Domperidone (I.R.) I.P. 10mg
Composition : Rabeprazole (20mg) + Itopride (150mg)
Composition : Lansoprazole (15mg) Tablet
Composition : Lansoprazole (30mg)
Composition : Levosulpiride (75mg) + Pantoprazole (40mg)
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Octrate 0.1 Injection, containing Octreotide acetate 0.1mg, has strong demand in the gastroenterology and endocrinology hospital segment, making it a high-value specialty injectable for medical distributors, wholesalers, and pharma franchise partners focusing on critical care and hospital-use products.
Medical distributors and agencies can benefit from the consistent hospital demand for somatostatin analogs used in conditions like acromegaly, carcinoid tumors, severe diarrhea (VIPomas), and management of certain endocrine disorders. Octrate 0.1 Injection helps strengthen a specialized ICU and gastro-endocrine injectable portfolio.
Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Octrate 0.1 Injection with promotional support, monopoly rights, quality packaging, and competitive pricing for distributors and wholesalers.
Wholesalers and medical agencies benefit from niche hospital demand, high-value prescription flow, reliable supply, and strong margins when partnering for Octrate 0.1 Injection distribution.
Medical distributors, stockists, and wholesalers interested in Octrate 0.1 Injection can contact Cafoli LifeCare Pvt Ltd to discuss franchise opportunities, bulk supply requirements, pricing, and distribution support.